Nov 3, 2024, 15:29
Krishan Jethwa: German Rectal Cancer Study Group informs prognostic significance of ypN+ after nCRT
Krishan Jethwa, GI Radiation Oncologist at Mayo Clinic, shared a post on X about a recent paper by Markus Diefenhardt et al. published in JAMA Network Open.
“German Rectal Cancer Study Group informs prognostic significance of ypN+ after nCRT
ypN+ (ypN2) associated with:
- High DM
- High Locoregional recurrence
- Low OS
Trials needed to explore post-op intensification? How to integrate with other biomarkers (eg ctDNA)?”
“Persistent Lymph Node Metastases After Neoadjuvant Chemoradiotherapy for Rectal Cancer”
Authors: Markus Diefenhardt, Daniel Martin, Ralf-Dieter Hofheinz, Michael Ghadimi, Emmanouil Fokas, Claus Rödel, Maximilian Fleischmann.
More posts featuring Krishan Jethwa.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 21, 2024, 06:49
Nov 20, 2024, 20:38
Nov 20, 2024, 20:27
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12